Viking Therapeutics Takeover Target in Biotech Investing?
Investors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
Certain bonds and fund structures minimize tax impact, making them attractive for retirees seeking reliable after-tax income.
22,683 articlesInvestors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
A spike in revenue can grab headlines, but it rarely tells the full investment story. Here’s why super micro computer...
Oklo edges toward its first commercial nuclear power with government negotiations and a European funding alliance, ex...
In 2022, the 3x levered ETF SOXL plunged about 90%, even as the broader semiconductor group endured a mid-cycle decli...
Investing in memory chips means weighing volatility against opportunity. This article digs into could micron technolo...
A major asset sale could recalibrate FMC’s balance sheet and growth trajectory. This guide breaks down what the deal ...
American Superconductor surprised on the top line but traded lower as short-sellers reared their heads. This article ...
When the next earnings season looms, a single well-chosen tech stock can outshine a broad, aimless portfolio. Learn h...
SpaceX’s latest IPO disclosures raise a rare self‑awareness moment: its own push for a crowded Low Earth Orbit could ...
The software market's laggard this year may be near a tipping point. Snowflake's recent performance hints that AI-dri...
A regulatory nod sparks a wave of excitement across crypto markets. Perpetual futures are back in the spotlight as tr...
As cars.com (cars) 2026 earnings begin to unfold, investors want clarity on revenue growth, margins, and cash flow. T...